CAMBRIDGE, MA – Seres Therapeutics, Inc. (NASDAQ:MCRB), a biopharmaceutical company specializing in pharmaceutical preparations, announced on Monday the appointment of Dr. Hans-Juergen Woerle as a new ...
CAMBRIDGE, Mass. - Seres Therapeutics, Inc. (NASDAQ:MCRB), a clinical-stage biotherapeutic company with a market capitalization of $133 million, announced today that it has received a $50 million ...
On January 9, 2025, Seres Therapeutics, Inc. (NASDAQ: MCRB) released significant updates regarding its recent achievements and financial standing. The company shared details from its preliminary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback